MoonLake Immunotherapeutics Return On Tangible Equity 2021-2024 | MLTX

MoonLake Immunotherapeutics return on tangible equity from 2021 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

MoonLake Immunotherapeutics Return On Tangible Equity 2021-2024 | MLTX

MoonLake Immunotherapeutics return on tangible equity from 2021 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.